Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only._x000D_
_x000D_
#How Much Is the Global Cross-Species Organ Transplantation Market Valued at Present and by 2029?#_x000D_
The market size for cross-species organ transplantation has seen robust growth in the recent past and this trend is expected to continue. The market, which was valued at $13.98 billion in 2024, is projected to reach $15.20 billion in 2025, growing at a compound annual growth rate (CAGR) of 8.7%. Various factors that contributed to its historical growth include the increase in animal model experimentation, the emergence of debates around bioethics, a surge in chronic diseases, experimental transplants from pigs to primates, and the high death rate due to terminal organ failure._x000D_
_x000D_
The cross-species organ transplantation market is anticipated to experience significant expansion in the upcoming years, rising to $20.95 billion by 2029 with a compound annual growth rate (CAGR) of 8.3%. This expected growth during the forecast period can be linked to an increased need for transplant organs, growth in investments towards regenerative medicine, worldwide chronic kidney and liver disease prevalence, advocacy by patients to secure transplants, and a decreasing number of human donors. Key trends to watch in the forecast period include the development of gene-edited pig organs, engineering human-compatible genomes, application of artificial intelligence in matching organs, 3D bio-printing of vascular structures, the technology of machine perfusion and preservation, and nanoscale drug delivery systems for immunosuppression._x000D_
_x000D_
#Download The Free Sample Report Here:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=27267&type=smp_x000D_
_x000D_
#What Drivers Are Influencing Growth In The Cross-Species Organ Transplantation Market?_x000D_
The upward trend in genetic engineering is projected to spur the expansion of the cross-species organ transplantation market. Genetic engineering involves the purposeful alteration of an organism’s DNA through biotechnology methods to introduce, eliminate, or change specific genes. The increased need for organ transplantation is creating an urgency to develop more compatible animal organs for human transplantation through genetic engineering. This form of engineering is fostering the growth of cross-species organ transplantation by facilitating the modification of animal organs to diminish immune rejection, rendering them suitable for human implants. To illustrate, the American Society of Gene & Cell Therapy (ASGCT), a US-based nonprofit medical and scientific institution, reported that there were 247 gene therapies in Phase II by the first quarter’s end in July 2023, escalating by 5% to touch 260 by the second quarter’s conclusion. As a result, the rise in genetic engineering is powering the growth of the cross-species organ transplantation market._x000D_
_x000D_
#What Are The Main Segments Identified In The Cross-Species Organ Transplantation Market Research?#_x000D_
The cross-species organ transplantation market covered in this report is segmented_x000D_
_x000D_
1) By Product Type: Organ Preservation Solution, Transplant Diagnostics, Xeno Products, Other Product Types_x000D_
2) By Application: Kidney, Heart, Liver, Lung, Other Applications_x000D_
3) By End-User: Transplant Centers, Hospitals, Other End-Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Organ Preservation Solution: Hypothermic Machine Perfusion (HMP) Solutions, Normothermic Machine Perfusion (NMP) Solutions, Static Cold Storage (SCS) Solutions, Oxygenated Perfusion Solutions _x000D_
2) By Transplant Diagnostics: Histocompatibility Testing, Crossmatching Tests, Molecular Typing (DNA-based Testing), Immunological Monitoring Assays _x000D_
3) By Xeno Products: Genetically Engineered Donor Organs, Decellularized Organ Scaffolds, Xenogeneic Cellular Therapies, Immunosuppressive Regimens For Xenotransplants _x000D_
4) By Other Product Types: Organ Transport Devices, Organ Recovery and Preservation Equipment, Surgical Instruments For Transplantation, Post-Transplant Monitoring Devices_x000D_
_x000D_
#What Are The Leading Trends And Opportunities In The Cross-Species Organ Transplantation Sector?#_x000D_
Top-tier businesses engaged in the interspecies organ transfer market are concentrating on forming strategic partnerships to simplify the regulatory approval process for xenotransplant solutions. A strategic partnership is a collaboration where firms leverage each other’s capabilities and resources to pursue shared objectives, with the intention to stimulate growth, innovation, and competitiveness without a merger. For example, in February 2025, United Therapeutics, a biotech firm based in the United States, and eGenesis, a pharmaceutical company also based in the U.S., initiated clinical trials for pig kidney (xenotransplant) in humans. This trial was greenlighted by the U.S. Food and Drug Administration (FDA) to transplant genetically modified pig kidneys into patients suffering from kidney failure. The trials are designed to tackle the pressing insufficiency of donor kidneys by potentially offering a novel, sustainable organ source for those in urgent need._x000D_
_x000D_
#Which Companies Play A Key Role In The Development Of The Cross-Species Organ Transplantation Market?#_x000D_
Major companies operating in the cross-species organ transplantation market are Pfizer Inc, F. Hoffmann-la Roche Ltd, Sanofi SA, Novartis AG, Optipharm Co Ltd, Astellas Pharma Inc., United Therapeutics Corporation, TransMedics Group Inc., Artivion Inc., eGenesis Inc., Organ Recovery Systems Inc., OrganOX Ltd, Paragonix Technologies Inc., Qihan Biotech, PorMedTec Co., XenoTheraputics Inc., Makana Therapeutics Inc., Preservation Solutions Inc., Nzeno Ltd, Infigen Inc. _x000D_
_x000D_
#Get The Full Report Here:#_x000D_
_x000D_
#What Are The Key Regional Developments Shaping The Cross-Species Organ Transplantation Market?#_x000D_
North America was the largest region in the cross-species organ transplantation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cross-species organ transplantation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Request For A Customized Report:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=27267&type=smp_x000D_
_x000D_
#About The Business Research Company:#_x000D_
_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 310-496-7795_x000D_
Asia +44 7882 955267 & +91 8897263534_x000D_
Europe +44 7882 955267_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model